Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Rising High: Exclusive talk with biotech company Tryp Therapeutics » 11:59
05/19/22
05/19
11:59
05/19/22
11:59
GDNSF

Goodness Growth

$1.42 /

-0.05 (-3.40%)

, ZYNE

Zynerba

/

+

, TCNNF

Trulieve Cannabis

$14.37 /

-0.135 (-0.93%)

, TLRY

Tilray

$4.94 /

+0.15 (+3.13%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.67 /

-0.52 (-4.27%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.48 /

+0.155 (+4.66%)

, CGC

Canopy Growth

$5.89 /

+0.3 (+5.37%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$3.08 /

+0.175 (+6.02%)

, RLMD

Relmada Therapeutics

$21.30 /

-0.3 (-1.39%)

, CMPS

Compass Pathways

$8.59 /

+0.36 (+4.37%)

, ATAI

Atai Life Sciences

$4.07 /

+0.125 (+3.17%)

, TRYPF

Tryp Therapeutics

/

+

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TRYPF Tryp Therapeutics
/

+

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
ZYNE Zynerba
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.94 /

+0.15 (+3.13%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
CANN General Cannabis
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

05/20/22 Alliance Global Partners
Canopy Growth price target lowered to C$8 from C$11 at Alliance Global Partners
04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

05/17/22 Citi
Atai Life Sciences price target lowered to $22 from $26 at Citi
04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
TRYPF Tryp Therapeutics
/

+

08/26/21 Ladenburg
Tryp Therapeutics initiated with a Buy at Ladenburg
ZYNE Zynerba
/

+

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

TCNNF Trulieve Cannabis
$14.37 /

-0.135 (-0.93%)

RLMD Relmada Therapeutics
$21.30 /

-0.3 (-1.39%)

GTBIF Green Thumb Industries
$11.67 /

-0.52 (-4.27%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CMPS Compass Pathways
$8.59 /

+0.36 (+4.37%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

  • 09
    Dec
  • 18
    Jun
GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

GDNSF Goodness Growth
$1.42 /

-0.05 (-3.40%)

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

TLRY Tilray
$4.94 /

+0.15 (+3.13%)

CRON Cronos Group
$3.48 /

+0.155 (+4.66%)

CGC Canopy Growth
$5.89 /

+0.3 (+5.37%)

ATAI Atai Life Sciences
$4.07 /

+0.125 (+3.17%)

ACB Aurora Cannabis
$3.08 /

+0.175 (+6.02%)

Wednesday
Hot Stocks
Aurora Cannabis receives EU-GMP certification for facility in Germany » 07:06
05/18/22
05/18
07:06
05/18/22
07:06
ACB

Aurora Cannabis

$3.09 /

+0.155 (+5.28%)

Aurora Cannabis announced…

Aurora Cannabis announced the company has received EU-GMP certification for its state-of-the-art medical cannabis production facility in Germany. As a leading manufacturer of medical cannabis worldwide, achieving EU-GMP certification of the company's first German manufacturing site marks a significant milestone in the fulfillment of an awarded tender by the German Federal Institute for Drugs and Medical Devices. Aurora is the distinct market leader in the German flower segment and will now leverage receiving the world's highest quality standard to produce and distribute premium medical cannabis in Germany.

ShowHide Related Items >><<
ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

05/16/22 CIBC
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC
05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

ACB Aurora Cannabis
$3.09 /

+0.155 (+5.28%)

Monday
Recommendations
Aurora Cannabis price target lowered to C$3.75 from C$6.50 at CIBC » 12:35
05/16/22
05/16
12:35
05/16/22
12:35
ACB

Aurora Cannabis

$2.96 /

+0.14 (+4.96%)

CIBC analyst John Zamparo…

CIBC analyst John Zamparo lowered the firm's price target on Aurora Cannabis to C$3.75 from C$6.50 and keeps a Neutral rating on the shares.

ShowHide Related Items >><<
ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

ACB Aurora Cannabis
$2.96 /

+0.14 (+4.96%)

Over a week ago
Recommendations
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald » 07:55
05/13/22
05/13
07:55
05/13/22
07:55
ACB

Aurora Cannabis

$2.42 /

+0.125 (+5.46%)

Cantor Fitzgerald analyst…

Cantor Fitzgerald analyst Pablo Zuanic lowered the firm's price target on Aurora Cannabis to C$3.90 from C$7.60 and keeps a Neutral rating on the shares. Aurora Cannabis increased cash cost savings targets which gives further credence to its goal of becoming EBITDA positive by this coming December on a run rate basis, Zuanic tells investors in a research note. Question marks remain about the lack of profitability and cash flows, Zuanic adds.

ShowHide Related Items >><<
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

Hot Stocks
Aurora Cannabis raises expense savings target to C$150M-C$170M » 16:20
05/12/22
05/12
16:20
05/12/22
16:20
ACB

Aurora Cannabis

$2.42 /

+0.125 (+5.46%)

Now expects C$150M-C$170M…

Now expects C$150M-C$170M in Annualized cost savings by H1/2023 versus stated target of C$60M-C$80M. "We continue to steer our differentiated global cannabis business towards long term shareholder value creation. This is being accomplished through a sole focus on the most profitable growth opportunities, rationalization of our Canadian cost structure and disciplined use of capital. Our plan is working and we remain firmly on track to achieving a positive Adjusted EBITDA run rate by the first half of fiscal 2023. Today, we are announcing further cost savings which will enable us to increase our range of savings under our business transformation plan from $60 to $80 million to $150 to $170 million. Our balance sheet also remains among the strongest in the industry, enabling the repurchase of $141.4 million in convertible debt early, while also providing meaningful working capital to support organic growth and pursue strategic M&A, such as our recent acquisition of Thrive Cannabis," stated Miguel Martin, CEO of Aurora.

ShowHide Related Items >><<
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

Earnings
Aurora Cannabis reports Q3 revenue C$50.43M vs. C$55.16M a year ago » 16:18
05/12/22
05/12
16:18
05/12/22
16:18
ACB

Aurora Cannabis

$2.42 /

+0.125 (+5.46%)

Adjusted gross margin…

Adjusted gross margin before fair value adjustments on cannabis net revenue was 54% in Q3 2022 versus 53% in the prior quarter and 44% in Q3 2021. The increase in adjusted gross margin compared to the prior year period is due to increased sales in our international medical markets which command significantly higher average net selling prices and margins.

ShowHide Related Items >><<
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

ACB Aurora Cannabis
$2.42 /

+0.125 (+5.46%)

Options
Aurora Cannabis options imply 13.6% move in share price post-earnings » 14:04
05/12/22
05/12
14:04
05/12/22
14:04
ACB

Aurora Cannabis

$2.34 /

+0.05 (+2.18%)

Pre-earnings options…

Pre-earnings options volume in Aurora Cannabis is 2.3x normal with calls leading puts 7:4. Implied volatility suggests the market is anticipating a move near 13.6%, or 32c, after results are released. Median move over the past eight quarters is 10.2%.

ShowHide Related Items >><<
ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

ACB Aurora Cannabis
$2.34 /

+0.05 (+2.18%)

On The Fly
Rising High: Exclusive talk with cannabis REIT NewLake Capital » 11:42
05/12/22
05/12
11:42
05/12/22
11:42
RLMD

Relmada Therapeutics

$18.51 /

-0.07 (-0.38%)

, CMPS

Compass Pathways

$7.03 /

+0.23 (+3.38%)

, ATAI

Atai Life Sciences

$3.32 /

+0.19 (+6.07%)

, ZYNE

Zynerba

/

+

, TCNNF

Trulieve Cannabis

$13.60 /

-0.43 (-3.06%)

, TLRY

Tilray

$4.43 /

+0.37 (+9.11%)

, IGC

India Globalization Capital

/

+

, GTBIF

Green Thumb Industries

$11.76 /

+0.05 (+0.43%)

, GDNSF

Goodness Growth

$1.49 /

-0.032 (-2.11%)

, CANN

General Cannabis

/

+

, CRON

Cronos Group

$3.14 /

+0.15 (+5.02%)

, CGC

Canopy Growth

$5.47 /

+0.49 (+9.84%)

, CTST

CannTrust

/

+

, CVSI

CV Sciences

/

+

, ACB

Aurora Cannabis

$2.47 /

+0.175 (+7.64%)

, NLCP

NewLake Capital Partners

$19.88 /

+0.03 (+0.15%)

In this edition of…

ShowHide Related Items >><<
ZYNE Zynerba
/

+

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

GDNSF Goodness Growth
$1.49 /

-0.032 (-2.11%)

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

05/09/22 Oppenheimer
Relmada Therapeutics price target lowered to $64 from $75 at Oppenheimer
12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Maxim
Atai Life Sciences initiated with a Buy at Maxim
ZYNE Zynerba
/

+

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

05/12/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$50 from C$60 at Alliance Global Partners
03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
TLRY Tilray
$4.43 /

+0.37 (+9.11%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
GDNSF Goodness Growth
$1.49 /

-0.032 (-2.11%)

05/12/22 Canaccord
Goodness Growth price target lowered to C$3.50 from C$4 at Canaccord
02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
CANN General Cannabis
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

05/11/22 CIBC
CIBC upgrades Cronos to buy on 'multiple reasons for optimism'
05/11/22 Canaccord
Cronos upgraded to Hold on operational improvements at Canaccord
05/11/22 CIBC
Cronos Group upgraded to Outperformer from Neutral at CIBC
05/11/22 Canaccord
Cronos Group upgraded to Hold from Sell at Canaccord
CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
03/01/22 Barclays
Canopy Growth price target lowered to $9 from $14 at Barclays
CTST CannTrust
/

+

CVSI CV Sciences
/

+

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

05/13/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$3.90 from C$7.60 at Cantor Fitzgerald
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

03/21/22 Ladenburg
NewLake Capital price target lowered to $39.50 from $44 at Ladenburg
09/08/21 Compass Point
NewLake Capital Partners initiated with a Buy at Compass Point
09/07/21 Ladenburg
NewLake Capital Partners initiated with a Buy at Ladenburg
ZYNE Zynerba
/

+

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

TCNNF Trulieve Cannabis
$13.60 /

-0.43 (-3.06%)

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

GTBIF Green Thumb Industries
$11.76 /

+0.05 (+0.43%)

CVSI CV Sciences
/

+

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CMPS Compass Pathways
$7.03 /

+0.23 (+3.38%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

  • 09
    Dec
  • 18
    Jun
ZYNE Zynerba
/

+

RLMD Relmada Therapeutics
$18.51 /

-0.07 (-0.38%)

NLCP NewLake Capital Partners
$19.88 /

+0.03 (+0.15%)

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

TLRY Tilray
$4.43 /

+0.37 (+9.11%)

CRON Cronos Group
$3.14 /

+0.15 (+5.02%)

CGC Canopy Growth
$5.47 /

+0.49 (+9.84%)

ATAI Atai Life Sciences
$3.32 /

+0.19 (+6.07%)

ACB Aurora Cannabis
$2.47 /

+0.175 (+7.64%)

Options
Unusually active option classes on open May 10th » 09:40
05/10/22
05/10
09:40
05/10/22
09:40
VTNR

Vertex Energy

$9.49 /

+ (+0.00%)

, ACB

Aurora Cannabis

$2.53 /

+ (+0.00%)

, NOK

Nokia

$4.78 /

+ (+0.00%)

, FCEL

FuelCell

$3.50 /

+0.005 (+0.14%)

, TBT

ProShares UltraShort 20+ yr Trsry

$26.76 /

+0.005 (+0.02%)

, RIVN

Rivian Automotive

$22.60 /

+ (+0.00%)

, LI

Li Auto

$18.91 /

+ (+0.00%)

, XLK

Technology Select Sector SPDR

$135.27 /

+ (+0.00%)

, MO

Altria Group

$55.26 /

+ (+0.00%)

, EMB

iShares JP Morgan USD Emerging Markets Bond ETF

$88.55 /

+ (+0.00%)

Unusual total active…

Unusual total active option classes on open include: Vertex Energy (VTNR), Aurora Cannabis (ACB), Nokia (NOK), FuelCell (FCEL), ProShares UltraShort Lehman 20 plus Year Treasury (TBT), Rivian (RIVN), Li Auto (LI), Technology Sector SPDR ETF (XLK), Altria Group (MO), and iShares Emerging Markets Bond ETF (EMB).

ShowHide Related Items >><<
VTNR Vertex Energy
$9.49 /

+ (+0.00%)

RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

NOK Nokia
$4.78 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

LI Li Auto
$18.91 /

+ (+0.00%)

FCEL FuelCell
$3.50 /

+0.005 (+0.14%)

ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

VTNR Vertex Energy
$9.49 /

+ (+0.00%)

12/01/21 Credit Suisse
Vertex Energy initiated with an Outperform at Credit Suisse
11/09/21 Craig-Hallum
Vertex Energy price target lowered to $18 from $25 at Craig-Hallum
06/30/21 Craig-Hallum
Vertex Energy price target raised to $25 from $13 at Craig-Hallum
06/01/21 Stifel
Vertex Energy price target raised to $17 from $2 at Stifel
ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
NOK Nokia
$4.78 /

+ (+0.00%)

04/29/22 UBS
Nokia price target lowered to EUR 5.80 from EUR 6.20 at UBS
04/29/22 Societe Generale
Nokia price target lowered to EUR 6.10 from EUR 6.70 at Societe Generale
03/17/22 Jefferies
Nokia initiated with a Buy at Jefferies
03/14/22 Raymond James
Raymond James upgrades Nokia to Outperform on improved position
FCEL FuelCell
$3.50 /

+0.005 (+0.14%)

04/26/22 KeyBanc
KeyBanc says Axios report positive for Plug Power, other fuel cell names
02/08/22 B. Riley
FuelCell price target lowered to $5 from $6 at B. Riley
01/20/22 JPMorgan
FuelCell price target lowered to $5 from $7 at JPMorgan
01/05/22 KeyBanc
FuelCell initiated with a Sector Weight at KeyBanc
TBT ProShares UltraShort 20+ yr Trsry
$26.76 /

+0.005 (+0.02%)

RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

05/02/22 Piper Sandler
Piper Sandler favors Rivian for exposure to commercial vans
05/02/22 Benchmark
Ford price target lowered to $25 from $29 at Benchmark
04/26/22 Barclays
Rivian Automotive price target lowered to $38 from $42 at Barclays
04/25/22 JPMorgan
Ford price target lowered to $21 from $22 at JPMorgan
LI Li Auto
$18.91 /

+ (+0.00%)

04/04/22 UBS
Li Auto price target raised to $52 from $47 at UBS
04/01/22 HSBC
Li Auto initiated with a Buy at HSBC
03/24/22 China Renaissance
China Renaissance starts 'bellwether' Li Auto with Buy, $37.20 target
03/23/22 China Renaissance
Li Auto initiated with a Buy at China Renaissance
XLK Technology Select Sector SPDR
$135.27 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

05/10/22 Bernstein
Altria Group downgraded to Market Perform from Outperform at Bernstein
05/09/22 Jefferies
PM buying Swedish Match would have negative read for Altria, says Jefferies
04/29/22 Deutsche Bank
Altria Group price target raised to $60 from $54 at Deutsche Bank
04/07/22 Cowen
Altria Group price target raised to $53 from $51 at Cowen
EMB iShares JP Morgan USD Emerging Markets Bond ETF
$88.55 /

+ (+0.00%)

VTNR Vertex Energy
$9.49 /

+ (+0.00%)

RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

NOK Nokia
$4.78 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

LI Li Auto
$18.91 /

+ (+0.00%)

FCEL FuelCell
$3.50 /

+0.005 (+0.14%)

ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

  • 10
    Nov
  • 13
    Aug
RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

NOK Nokia
$4.78 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

LI Li Auto
$18.91 /

+ (+0.00%)

ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

VTNR Vertex Energy
$9.49 /

+ (+0.00%)

RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

NOK Nokia
$4.78 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

LI Li Auto
$18.91 /

+ (+0.00%)

FCEL FuelCell
$3.50 /

+0.005 (+0.14%)

ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

VTNR Vertex Energy
$9.49 /

+ (+0.00%)

TBT ProShares UltraShort 20+ yr Trsry
$26.76 /

+0.005 (+0.02%)

RIVN Rivian Automotive
$22.60 /

+ (+0.00%)

NOK Nokia
$4.78 /

+ (+0.00%)

MO Altria Group
$55.26 /

+ (+0.00%)

LI Li Auto
$18.91 /

+ (+0.00%)

FCEL FuelCell
$3.50 /

+0.005 (+0.14%)

ACB Aurora Cannabis
$2.53 /

+ (+0.00%)

XLK Technology Select Sector SPDR
$135.27 /

+ (+0.00%)

EMB iShares JP Morgan USD Emerging Markets Bond ETF
$88.55 /

+ (+0.00%)

On The Fly
Here's What You Missed in Cannabis, Psychedelics This Week » 11:42
05/05/22
05/05
11:42
05/05/22
11:42
GTBIF

Green Thumb Industries

$12.82 /

-0.22 (-1.69%)

, ETRGF

Entourage Health

/

+

, FFLWF

Fire & Flower Holdings

$2.66 /

+0.09 (+3.50%)

, CMPS

Compass Pathways

$9.11 /

-0.39 (-4.11%)

, WSNAF

Wesana Health

/

+

, TLRY

Tilray

$4.96 /

-0.35 (-6.59%)

, ACB

Aurora Cannabis

$2.95 /

-0.25 (-7.82%)

, CVSI

CV Sciences

/

+

, CTST

CannTrust

/

+

, CGC

Canopy Growth

$6.25 /

-0.45 (-6.72%)

, CRON

Cronos Group

$3.07 /

-0.175 (-5.39%)

, CANN

General Cannabis

/

+

, GDNSF

Goodness Growth

$1.65 /

-0.02 (-1.20%)

, IGC

India Globalization Capital

/

+

, TCNNF

Trulieve Cannabis

$13.75 /

+0.01 (+0.07%)

, ZYNE

Zynerba

$1.35 /

-0.05 (-3.57%)

, RLMD

Relmada Therapeutics

$23.27 /

-0.96 (-3.96%)

, ATAI

Atai Life Sciences

$4.04 /

-0.35 (-7.97%)

In this week's "Rising…

ShowHide Related Items >><<
ZYNE Zynerba
$1.35 /

-0.05 (-3.57%)

WSNAF Wesana Health
/

+

TLRY Tilray
$4.96 /

-0.35 (-6.59%)

TCNNF Trulieve Cannabis
$13.75 /

+0.01 (+0.07%)

RLMD Relmada Therapeutics
$23.27 /

-0.96 (-3.96%)

IGC India Globalization Capital
/

+

GTBIF Green Thumb Industries
$12.82 /

-0.22 (-1.69%)

GDNSF Goodness Growth
$1.65 /

-0.02 (-1.20%)

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CTST CannTrust
/

+

CRON Cronos Group
$3.07 /

-0.175 (-5.39%)

CMPS Compass Pathways
$9.11 /

-0.39 (-4.11%)

CGC Canopy Growth
$6.25 /

-0.45 (-6.72%)

ATAI Atai Life Sciences
$4.04 /

-0.35 (-7.97%)

ACB Aurora Cannabis
$2.95 /

-0.25 (-7.82%)

GTBIF Green Thumb Industries
$12.82 /

-0.22 (-1.69%)

05/05/22 Alliance Global Partners
Green Thumb price target lowered to C$38 from C$40 at Alliance Global
05/05/22 Craig-Hallum
Green Thumb Industries price target lowered to $25 from $35 at Craig-Hallum
05/05/22 Needham
Green Thumb Industries price target lowered to $26 from $33 at Needham
04/01/22 Alliance Global Partners
Senate remains the hurdle for MORE Act, says Alliance Global Partners
ETRGF Entourage Health
/

+

11/18/21 Canaccord
Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord
11/17/21 Canaccord
Entourage Health price target lowered to C$0.40 from C$0.60 at Canaccord
FFLWF Fire & Flower Holdings
$2.66 /

+0.09 (+3.50%)

04/28/22 Stifel
Fire & Flower Holdings price target lowered to C$8.50 from C$12 at Stifel
12/15/21 Stifel
Fire & Flower Holdings downgraded to Speculative Buy from Buy at Stifel
11/23/21 Cantor Fitzgerald
Fire & Flower Holdings initiated with an Overweight at Cantor Fitzgerald
11/22/21 Cantor Fitzgerald
Fire & Flower initiated with an Overweight at Cantor Fitzgerald
CMPS Compass Pathways
$9.11 /

-0.39 (-4.11%)

02/28/22 Canaccord
Compass Pathways price target lowered to $78 from $80 at Canaccord
11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
WSNAF Wesana Health
/

+

04/01/22 Stifel
Wesana Health initiated with a Speculative Buy at Stifel
TLRY Tilray
$4.96 /

-0.35 (-6.59%)

05/02/22 Alliance Global Partners
Tilray price target lowered to $5.50 from $8 at Alliance Global Partners
04/20/22 Barclays
Tilray price target lowered to $4.50 from $8.50 at Barclays
04/06/22 MKM Partners
Tilray margins contracted despite cost savings, says MKM Partners
04/06/22 Benchmark
Tilray fiscal Q3 results 'disappointing,' says Benchmark
ACB Aurora Cannabis
$2.95 /

-0.25 (-7.82%)

02/11/22 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$7.60 from C$10.75 at Cantor Fitzgerald
02/03/22 CIBC
Aurora Cannabis price target lowered to C$6.50 from C$9.25 at CIBC
11/11/21 Canaccord
Aurora Cannabis price target lowered to C$6 from C$6.50 at Canaccord
CVSI CV Sciences
/

+

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
CTST CannTrust
/

+

CGC Canopy Growth
$6.25 /

-0.45 (-6.72%)

04/04/22 Morgan Stanley
Constellation Brands price target lowered to $294 from $299 at Morgan Stanley
03/22/22 Barclays
Canopy Growth downgraded to Underweight from Equal Weight at Barclays
03/01/22 Barclays
Canopy Growth price target lowered to $9 from $14 at Barclays
CRON Cronos Group
$3.07 /

-0.175 (-5.39%)

03/22/22 Barclays
Cronos Group upgraded to Equal Weight from Underweight at Barclays
03/21/22 Stifel
Stifel takes neutral overall view of Cronos' CEO transition
03/07/22 Piper Sandler
Cronos Group price target lowered to $3 from $4 at Piper Sandler
CANN General Cannabis
/

+

GDNSF Goodness Growth
$1.65 /

-0.02 (-1.20%)

02/01/22 Craig-Hallum
Goodness Growth downgraded to Hold from Buy at Craig-Hallum
11/11/21 Canaccord
Goodness Growth price target lowered to C$2.75 from C$4.50 at Canaccord
IGC India Globalization Capital
/

+

TCNNF Trulieve Cannabis
$13.75 /

+0.01 (+0.07%)

03/31/22 Canaccord
Trulieve Cannabis price target lowered to C$65 from C$70 at Canaccord
03/30/22 Alliance Global Partners
Trulieve Cannabis price target lowered to C$60 from C$76 at Alliance Global Partners
03/29/22 Cantor Fitzgerald
Trulieve Cannabis price target lowered to $60 from $72 at Cantor Fitzgerald
ZYNE Zynerba
$1.35 /

-0.05 (-3.57%)

05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
RLMD Relmada Therapeutics
$23.27 /

-0.96 (-3.96%)

12/20/21 SVB Leerink
Relmada Therapeutics price target lowered to $42 from $50 at SVB Leerink
11/17/21 Mizuho
Relmada Therapeutics initiated with a Buy at Mizuho
09/30/21 Jefferies
Jefferies says Street discounting importance of Relmada's Phase 2 mono MDD study
07/28/21 Truist
Relmada Therapeutics price target raised to $90 from $75 at Truist
ATAI Atai Life Sciences
$4.04 /

-0.35 (-7.97%)

04/01/22 Canaccord
Atai Life Sciences price target lowered to $27 from $28 at Canaccord
03/31/22 RBC Capital
Atai Life Sciences price target lowered to $9 from $12 at RBC Capital
11/30/21
Fly Intel: Top five analyst initiations
11/30/21 Maxim
Atai Life Sciences initiated with a Buy at Maxim
ZYNE Zynerba
$1.35 /

-0.05 (-3.57%)

TLRY Tilray
$4.96 /

-0.35 (-6.59%)

RLMD Relmada Therapeutics
$23.27 /

-0.96 (-3.96%)

GTBIF Green Thumb Industries
$12.82 /

-0.22 (-1.69%)

ETRGF Entourage Health
/

+

CVSI CV Sciences
/

+

CRON Cronos Group
$3.07 /

-0.175 (-5.39%)

CMPS Compass Pathways
$9.11 /

-0.39 (-4.11%)

CGC Canopy Growth
$6.25 /

-0.45 (-6.72%)

ATAI Atai Life Sciences
$4.04 /

-0.35 (-7.97%)

ACB Aurora Cannabis
$2.95 /

-0.25 (-7.82%)

  • 09
    Dec
  • 18
    Jun
GTBIF Green Thumb Industries
$12.82 /

-0.22 (-1.69%)

WSNAF Wesana Health
/

+

GTBIF Green Thumb Industries
$12.82 /

-0.22 (-1.69%)

FFLWF Fire & Flower Holdings
$2.66 /

+0.09 (+3.50%)

TLRY Tilray
$4.96 /

-0.35 (-6.59%)

CRON Cronos Group
$3.07 /

-0.175 (-5.39%)

CMPS Compass Pathways
$9.11 /

-0.39 (-4.11%)

CGC Canopy Growth
$6.25 /

-0.45 (-6.72%)

ATAI Atai Life Sciences
$4.04 /

-0.35 (-7.97%)

ACB Aurora Cannabis
$2.95 /

-0.25 (-7.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.